Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-23

Clinical Trial Update: Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial [NA]

View source ↗

Summary

Completed clinical trial evaluating a medication risk communication and surveillance strategy (EMC2 trial).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwestern University | Conditions: High-risk Medications | NA | Status: COMPLETED | Results posted: 2020-10-23